Compare GEHC & TCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | TCOM |
|---|---|---|
| Founded | 1892 | 1999 |
| Country | United States | Singapore |
| Employees | N/A | 43574 |
| Industry | Computer Software: Prepackaged Software | Hotels/Resorts |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6B | 33.0B |
| IPO Year | 2022 | N/A |
| Metric | GEHC | TCOM |
|---|---|---|
| Price | $64.54 | $47.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $88.38 | $78.75 |
| AVG Volume (30 Days) | ★ 6.3M | 2.6M |
| Earning Date | 04-29-2026 | 05-18-2026 |
| Dividend Yield | 0.24% | ★ 0.57% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $20,625,000,000.00 | N/A |
| Revenue This Year | $7.12 | $15.73 |
| Revenue Next Year | $4.45 | $13.00 |
| P/E Ratio | $75.72 | ★ $9.06 |
| Revenue Growth | ★ 4.84 | N/A |
| 52 Week Low | $58.75 | $45.92 |
| 52 Week High | $89.77 | $79.00 |
| Indicator | GEHC | TCOM |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 33.07 |
| Support Level | $60.86 | N/A |
| Resistance Level | $75.65 | $54.81 |
| Average True Range (ATR) | 1.69 | 1.25 |
| MACD | 0.69 | -0.56 |
| Stochastic Oscillator | 84.91 | 18.12 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.